Charles Kind, DPM
Podiatrist · Monroe, WINPI 1245246198
Payments from drug & device makers
Across 33 payments — averaging $37.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$276
- Organogenesis Inc.$184
- Integra Lifesciences Corporation$169
- Kerecis Limited$138
- GRT US Holding, Inc.$125
- Johnson & Johnson$117
- plus $226 from 9 others
What the payments were for
- Food & beverage$1,235100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 10 | $276 |
| Organogenesis Inc. | 5 | $184 |
| Integra Lifesciences Corporation | 2 | $169 |
| Kerecis Limited | 1 | $138 |
| GRT US Holding, Inc. | 2 | $125 |
| Johnson & Johnson | 1 | $117 |
| Next Science LLC | 3 | $51 |
| Treace Medical Concepts, Inc. | 2 | $38 |
| Mimedx Group, Inc. | 1 | $36 |
| Orthofix Medical, Inc. | 1 | $20 |
| Urgo Medical North America, LLC | 1 | $19 |
| Medwest Associates | 1 | $18 |
| Medline Industries LP | 1 | $17 |
| Celularity Inc. | 1 | $14 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$466
- Kerecis Omega3 SurgiClose$414
- INTEGRA DERMAL REGENERATION TEMPLATE$155
- PRIMATRIX$155
- Stravix$146
- Grafix$146
- STRAVIX PL$146
- GRAFIX PL$146
- Kerecis Omega3 GraftGuide$138
- Kerecis Omega3 Marigen$138
- Puraply Antimicrobial$125
- UNIUM$117
- ELITE$117
- N/A$117
- NA$117
- SPEED$117
- Qutenza$107
How this compares
$1,235 in reported general payments places this provider in the 50th percentile of 140 podiatrist providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 61 | $524 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 56 | $459 |
| Levofloxacin | 113 | $421 |
| Doxycycline Monohydrate | 33 | $413 |
| Doxycycline Hyclate | 40 | $368 |
| Nystatin | 20 | $358 |
| Cephalexin | 17 | $151 |
| Methylprednisolone | 39 | $144 |
| Hydrocortisone | 19 | $108 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $64 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Monroe
- Bradley Abichtla Crosse$313K
- Scott Carringtonla Crosse$116K
- Christopher MilkieWauwatosa$38K
- Jason DevriesManitowoc$31K
- Randall DeiFranklin$20K
- Michael NuteKenosha$13K
- Jacob HagenbucherMadison$13K
- Andrea CifaldiEau Claire$13K
- Jonathan ShihFranklin$11K
- Naren PatelMadison$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.